Theravance Biopharma, Inc. (TBPH) — Stock Score Summary

Theravance Biopharma, Inc. (TBPH) has a MoatMap StockRank of 71/100 based on Quality (71/100), Value (40/100), and Momentum (44/100) factor scores. The current signal is BUY. Theravance is a biopharmaceutical firm lacking the scale, proprietary CDMO platform, or clear commercial momentum needed to justify a position under our quality and macro frameworks.

Theravance Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. The company's competitive moat is built on its proprietary expertise in multivalent drug design, which optimizes therapeutic index and safety profiles. It operates as a specialized biotechnology player targeting respiratory and gastrointestinal diseases.

Key Financial Metrics

Price$16.49
Market Cap$836M
P/E (TTM)7.34
P/E (Forward)13.04
Price/Book2.90
Return on Equity50.2%
Return on Invested Capital29.4%
Debt/Equity13.94
Gross Margin71.0%
Operating Margin-33.1%
Revenue Growth15.0%
Free Cash Flow$23M

Theravance Biopharma, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Theravance Biopharma, Inc.’s (TBPH) StockRank?
MoatMap’s StockRank for Theravance Biopharma, Inc. (TBPH) is 71/100, with a Buy signal. It is a composite of Quality (71), Value (40), and Momentum (44) factor ranks across MoatMap’s 19,000+ stock universe.
Does Theravance Biopharma, Inc. have an economic moat?
Theravance Biopharma, Inc. (TBPH) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Theravance Biopharma, Inc. a buy, hold, or sell?
MoatMap’s current signal for Theravance Biopharma, Inc. (TBPH) is Buy, based on a StockRank of 71/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Theravance Biopharma, Inc. in?
Theravance Biopharma, Inc. (TBPH) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksTBPH deep dive reportAI ChampionsHow we score stocksSense-check another stock